Product image of Kandrozid (Candesartan Cilexetil) supplied by GNH India

Kandrozid

Active Ingredient:
Candesartan Cilexetil
Origin:
EU

Kandrozid (Candesartan Cilexetil)

Candesartan Cilexetil, the active ingredient in Kandrozid, is an angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It is employed to lower high blood pressure and to manage heart failure in adult patients.

GNH India supplies Kandrozid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Our distribution network ensures timely delivery and compliance with local regulatory requirements.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Candesartan Cilexetil is an angiotensin II receptor blocker used to treat conditions related to the renin‑angiotensin system.
  • Hypertension: lowers systolic and diastolic blood pressure, reducing the risk of stroke and cardiovascular events.
  • Heart Failure: improves symptoms, decreases hospital admissions, and enhances survival in patients with reduced ejection fraction.
  • Left Ventricular Dysfunction after Myocardial Infarction: helps prevent adverse cardiac remodeling and supports functional recovery.

How It Works

  • Candesartan Cilexetil is a selective antagonist of angiotensin II type 1 (AT1) receptors. By blocking these receptors, it prevents angiotensin II‑mediated vasoconstriction, aldosterone secretion, and sympathetic activation, leading to vasodilation, reduced sodium and water retention, and ultimately lower arterial pressure and cardiac workload.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Dizziness
  • Headache
  • Fatigue
  • Upper respiratory tract infection
  • Diarrhea
  • Nasal congestion

Serious or Rare Side Effects

  • Angioedema
  • Severe hyperkalemia
  • Acute renal impairment
  • Hepatic dysfunction
  • Symptomatic hypotension
  • Neutropenia

Precautions & Warnings

Patients should be monitored for safety and appropriate use.

  • Blood pressure monitoring: check regularly to ensure therapeutic effect and avoid hypotension.
  • Renal function assessment: evaluate serum creatinine and eGFR before and during therapy.
  • Serum potassium: monitor for hyperkalemia, especially when combined with potassium‑sparing agents.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Hypersensitivity: discontinue if signs of allergic reaction appear.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Potential drug interactions require careful management.

Major Interactions (Avoid)

  • ACE inhibitors: combined use may increase risk of hyperkalemia and renal dysfunction.
  • Aliskiren (in pregnancy): concurrent use is contraindicated due to enhanced adverse renal effects.
  • Potassium‑sparing diuretics or supplements: may cause dangerous elevations in serum potassium.

Moderate Interactions (Monitor Closely)

  • NSAIDs: can attenuate antihypertensive efficacy and affect renal function.
  • Lithium: may increase lithium concentrations, necessitating serum level monitoring.
  • Thiazide diuretics: may potentiate hypotensive effect, requiring dose adjustments.

Frequently Asked Questions

Kandrozid contains candesartan cilexetil, an angiotensin II receptor blocker indicated for the treatment of hypertension and for managing heart failure with reduced ejection fraction in adult patients.

Candesartan cilexetil selectively blocks AT1 receptors, preventing angiotensin II from causing vasoconstriction and aldosterone release. This leads to vessel relaxation, reduced sodium retention, and lower blood pressure, easing the workload on the heart.

The appropriate dose of Kandrozid is determined individually by a qualified prescriber based on the patient’s clinical condition, blood pressure response, and any concomitant therapies. No fixed regimen is provided here.

Safety data for candesartan cilexetil in pregnancy are limited, and the drug is generally avoided because of potential fetal toxicity. Use during breastfeeding is not recommended unless the benefit outweighs the risk, and a healthcare professional should be consulted.

To order Kandrozid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with ACE inhibitors, candesartan offers similar blood‑pressure control but a lower incidence of cough. Unlike calcium‑channel blockers, it directly blocks the renin‑angiotensin system, providing added benefits in heart‑failure patients and reducing proteinuria in some renal conditions.

Kandrozid tablets should be stored at room temperature, below 25 °C, in the original packaging. Protect them from moisture, excessive heat, and direct sunlight to maintain potency throughout the shelf life.

Kandrozid is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious adverse events include angioedema, severe hyperkalemia, acute renal impairment, and symptomatic hypotension. Patients should seek immediate medical attention if they experience swelling of the face or throat, rapid heartbeat, marked dizziness, or sudden loss of kidney function.

Kandrozid should be avoided in individuals with known hypersensitivity to candesartan or any ARB, in patients with severe hepatic impairment, and in those with a history of angioedema related to renin‑angiotensin system blockers.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Candesartan Cilexetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT